BD to Announce Financial Results for its Third Quarter of Fiscal 2025
BD (NYSE: BDX) has announced it will host an audio webcast on August 7, 2025, at 8 a.m. ET to discuss its third quarter fiscal 2025 financial results. The quarter ends on June 30, 2025. During the webcast, management will present the quarterly financial performance and provide updates on the company's operations and strategy.
The webcast will be accessible through BD's investor relations website, with presentation materials and a summary of financial information to be released prior to the call. A replay of the webcast will be available on the same website shortly after the event.
BD (NYSE: BDX) ha annunciato che terrà una trasmissione audio in webcast il 7 agosto 2025 alle 8:00 ET per discutere i risultati finanziari del terzo trimestre dell'anno fiscale 2025. Il trimestre si conclude il 30 giugno 2025. Durante il webcast, la direzione presenterà le performance finanziarie trimestrali e fornirà aggiornamenti sulle operazioni e sulla strategia dell'azienda.
Il webcast sarà accessibile tramite il sito web delle relazioni con gli investitori di BD, con materiali di presentazione e un riepilogo delle informazioni finanziarie che saranno resi disponibili prima della chiamata. Una replica del webcast sarà disponibile sullo stesso sito poco dopo l'evento.
BD (NYSE: BDX) ha anunciado que realizará una transmisión de audio en webcast el 7 de agosto de 2025 a las 8 a.m. ET para discutir los resultados financieros del tercer trimestre del año fiscal 2025. El trimestre finaliza el 30 de junio de 2025. Durante el webcast, la dirección presentará el desempeño financiero trimestral y proporcionará actualizaciones sobre las operaciones y la estrategia de la compañÃa.
El webcast estará disponible a través del sitio web de relaciones con inversores de BD, con materiales de presentación y un resumen de la información financiera que se publicarán antes de la llamada. Una repetición del webcast estará disponible en el mismo sitio poco después del evento.
BD (NYSE: BDX)ëŠ� 2025 íšŒê³„ì—°ë„ 3분기 재무 ê²°ê³¼ë¥� ë…¼ì˜í•˜ê¸° 위해 2025ë…� 8ì›� 7ì� ì˜¤ì „ 8ì‹� ETì—� 오디ì˜� 웹ìºìŠ¤íŠ¸ë¥� 개최í•� ì˜ˆì •ìž„ì„ ë°œí‘œí–ˆìŠµë‹ˆë‹¤. 해당 분기ëŠ� 2025ë…� 6ì›� 30ì¼ì— 종료ë©ë‹ˆë‹�. 웹ìºìŠ¤íŠ¸ ë™ì•ˆ ê²½ì˜ì§„ì€ ë¶„ê¸°ë³� 재무 성과ë¥� ë°œí‘œí•˜ê³ íšŒì‚¬ì� ìš´ì˜ ë°� ì „ëžµì—� 대í•� ì—…ë°ì´íЏë¥� ì œê³µí•� 것입니다.
웹ìºìŠ¤íŠ¸ëŠ� BDì� 투ìžìž� ê´€ê³� 웹사ì´íЏë¥� 통해 ì ‘ì†í•� ìˆ� 있으ë©�, 발표 ìžë£Œì™€ 재무 ì •ë³´ ìš”ì•½ì€ í†µí™” ì „ì— ê³µê°œë� ì˜ˆì •ìž…ë‹ˆë‹�. 웹ìºìŠ¤íŠ¸ ë…¹í™”ë³¸ì€ í–‰ì‚¬ ì§í›„ ë™ì¼ 웹사ì´íЏì—서 ì œê³µë� ì˜ˆì •ìž…ë‹ˆë‹�.
BD (NYSE : BDX) a annoncé qu'elle diffusera un webcast audio le 7 août 2025 à 8h00 ET pour discuter des résultats financiers du troisième trimestre de l'exercice 2025. Le trimestre se termine le 30 juin 2025. Lors du webcast, la direction présentera les performances financières trimestrielles et fournira des mises à jour sur les opérations et la stratégie de l'entreprise.
Le webcast sera accessible via le site web des relations investisseurs de BD, avec les supports de présentation et un résumé des informations financières qui seront publiés avant l'appel. Une rediffusion du webcast sera disponible sur le même site peu après l'événement.
BD (NYSE: BDX) hat angekündigt, am 7. August 2025 um 8 Uhr ET ein Audio-Webcast abzuhalten, um die Finanzergebnisse des dritten Quartals des Geschäftsjahres 2025 zu besprechen. Das Quartal endet am 30. Juni 2025. Während des Webcasts wird das Management die quartalsbezogenen Finanzergebnisse präsentieren und Updates zu den Unternehmensaktivitäten und der Strategie geben.
Der Webcast wird über die Investor-Relations-Website von BD zugänglich sein, wobei Präsentationsmaterialien und eine Zusammenfassung der Finanzinformationen vor dem Anruf veröffentlicht werden. Eine Aufzeichnung des Webcasts wird kurz nach der Veranstaltung auf derselben Website verfügbar sein.
- None.
- None.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at , X (formerly Twitter) or Instagram .Ìý
Contacts:
Media: | Investors: |
View original content:
SOURCE BD (Becton, Dickinson and Company)